Loading...

SeqLL Inc.

SQL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$6.60
$-0.16(-2.38%)

SeqLL Inc. (SQL) Stock Overview

Explore SeqLL Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.0/100

Key Financials

Market Cap2.5M
P/E Ratio-2.51
EPS (TTM)$-16.40
ROE10.89%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 Months$3.80
1 Year Target$2.23

SQL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SeqLL Inc. (SQL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.51 and a market capitalization of 2.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for SQLStats details for SQL are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for SQLAnalyst Recommendations details for SQL are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.

CEO

Daniel Robert Jones

Employees

7

Headquarters

3 Federal Street, Billerica, MA

Founded

2021

Frequently Asked Questions

;